naproxen

(redirected from Vimovo)
Also found in: Thesaurus, Medical, Encyclopedia.

na·prox·en

 (nə-prŏk′sən)
n.
A nonsteroidal anti-inflammatory drug, C14H14O3, used to treat fever and pain.

[Shortening and alteration of methoxynaphthylpropionic acid, one of its chemical names.]

naproxen

(nəˈprɒksɛn)
n
(Pharmacology) a drug with anti-inflammatory and pain-relieving properties

na•prox•en

(nəˈprɒk sən)

n.
a nonsteroidal anti-inflammatory substance, C14H14O3.
[by shortening and rearrangement of methoxy-, naphthyl-, and propionic, components of one of its chemical names]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.naproxen - a nonsteroidal anti-inflammatory drug (trade name Naprosyn) used in the treatment of arthritis and musculoskeletal inflammation and moderate pain
nonsteroidal anti-inflammatory, nonsteroidal anti-inflammatory drug, NSAID - an anti-inflammatory drug that does not contain steroids; "NSAIDs inhibit the activity of both Cox-1 and Cox-2 enzymes"
propanoic acid, propionic acid - a liquid fatty acid found in milk and sweat and in fuel distillates
Translations

naproxen

n naproxeno
References in periodicals archive ?
'While the Vimovo news during the quarter was disappointing, we have made cost-saving adjustments to our operations and our underlying business and financial performance is expected to benefit from these changes moving forward.'
In a regulatory filing, Horizon Pharma (HZNP) disclosed that on July 30, the Federal Circuit Court of Appeals denied Horizon Therapeutics' request for a rehearing of the Court's invalidity ruling against the 6,926,907 and 8,557,285 patents for VIMOVO coordinated-release tablets.
Within the same agreement, an additional $33m reflected the sale of the global rights (excluding the US and Japan) to Vimovo. The agreement completed in Q4 2018
that Nuvo's previously reported acquisition of Aralez's Canadian business and the Vimovo royalty stream was the most favourable bid received and that Aralez would seek court approval for the transaction.
M2 EQUITYBITES-March 18, 2019-Nuvo Pharmaceuticals Files Business Acquisition Report Related to Purchase of Aralez Pharmaceuticals Canada, US and International Rights to Vimovo and other Related Assets
Nuvo Pharmaceuticals has also acquired the global rights and royalties from licensees for Vimovo, Yosprala and global, ex-US product rights to MT400 that is presently commercialised in the United States as Treximet.
Global Banking News-October 31, 2018-AstraZeneca signs agreement to divest rights to Nexium in Europe and Vimovo worldwide (ex-US) to GrA1/4nenthal
* The Irish company Horizon Pharma's incredible price-hike of Vimovo is particularly notable because the drug is comprised of naproxen and esomeprazole, two medications that are available separately for much less--about $36 total.
The Journal cites similar increases for Ofirmev pain injections and Vimovo pain tablets after new companies acquired the rights.
The PPI products listed in the communication are AcipHex (rabeprazole sodium); Dexi-lant (dexlansoprazole); Nexium (esomeprazole magnesium); omeprazole over-the-counter (OTC); Prevacid (lansoprazole) and OTC Prevacid 24hr; Prilosec (omeprazole) and its OTC product, Protonix (pantoprazole sodium); Vimovo (esomeprazole magnesium and naproxen); and Zegerid (omeprazole and sodium bicarbonate) and its OTC product.
The PPI products listed in the communication are AcipHex (rabeprazole sodium); Dexilant (dexlansoprazole); Nexium (esomeprazole magnesium); omeprazole over-the-counter (OTC);Prevacid (lansoprazole) and OTC Prevacid 24hr; Prilosec (omeprazole) and its OTC product, Protonix (pantoprazole sodium); Vimovo (esomeprazole magnesium and naproxen); and Zegerid (omeprazole and sodium bicarbonate) and its OTC product.